Want to see HSTM full AI Analyst Report?
HSTM Stock Chart & Stats
$28.76
$0.98(3.52%)
At close: 4:00 PM EDT
$28.76
$0.98(3.52%)
Day’s Range― - ―
52-Week Range$19.50 - $34.48
Previous Close$28.85
Volume173.83K
Average Volume (3M)190.32K
Market Cap
$1.03B
Enterprise Value$745.50M
Total Cash (Recent Filing)$66.73M
Total Debt (Recent Filing)$13.43M
Price to Earnings (P/E)46.8
Beta0.66
Next Earnings
Oct 26, 2026EPS Estimate
0.16Next Dividend Ex-DateN/A
Dividend Yield0.41%
Share Statistics
EPS (TTM)0.72
Shares Outstanding30,595,886
10 Day Avg. Volume194,854
30 Day Avg. Volume190,322
Financial Highlights & Ratios
PEG Ratio-4.99
Price to Book (P/B)1.96
Price to Sales (P/S)2.28
P/FCF Ratio11.61
Enterprise Value/Market Cap0.72
Enterprise Value/Revenue2.32
Enterprise Value/Gross Profit3.57
Enterprise Value/Ebitda10.39
Forecast
1Y Price Target
$32.50Price Target Upside13.00% Upside
Rating ConsensusHold
Number of Analyst Covering4
EPS Forecast (FY)0.74
Revenue Forecast (FY)$329.93M
Bulls Say, Bears Say
Bulls Say
Recurring Subscription ModelThe highly recurring revenue base improves visibility and supports durable customer relationships across healthcare organizations. A $685 million performance obligation balance, with substantial amounts expected to convert within two years, provides a foundation for continued revenue realization and planning confidence.
Strong Cash Generation And Balance SheetStrong operating and free cash flow gives HealthStream internal funding capacity for product investment, acquisitions, and shareholder returns. Combined with very low leverage, this reduces financial strain and preserves flexibility to pursue growth initiatives through changing healthcare technology conditions.
Broad-based Product And Revenue GrowthGrowth across multiple subscription products indicates expanding demand rather than reliance on a single application. Strong performance in workforce, credentialing, competency, and clinical exchange offerings can deepen customer adoption, increase cross-selling potential, and reinforce HealthStream’s position in healthcare workflow software.
Bears Say
Legacy Product DeclineThe decline in legacy credentialing and scheduling revenue creates a transition burden as customers move to newer products. Even if migration supports longer-term modernization, shrinking legacy revenue can pressure near-term growth, require implementation resources, and make execution across the product portfolio more important.
Higher Operating ExpensesElevated spending on product development, sales, marketing, labor, software, royalties, and hosting is reducing the immediate conversion of revenue growth into net income. These investments may support future expansion, but sustained cost growth could constrain margin improvement and earnings growth if returns take longer to develop.
Cybersecurity InvestigationAn unresolved cybersecurity incident remains a business risk because HealthStream operates cloud software used for healthcare workforce and administrative workflows. While management does not currently expect material financial impact or customer-system compromise, investigation outcomes could affect remediation costs, trust, and operating priorities.
HealthStream News
HSTM FAQ
What was Healthstream’s price range in the past 12 months?
Healthstream lowest stock price was $19.50 and its highest was $34.48 in the past 12 months.
What is Healthstream’s market cap?
Healthstream’s market cap is $1.03B.
When is Healthstream’s upcoming earnings report date?
Healthstream’s upcoming earnings report date is Oct 26, 2026 which is in 3 days.
How were Healthstream’s earnings last quarter?
Healthstream released its earnings results on Aug 03, 2026. The company reported $0.23 earnings per share for the quarter, beating the consensus estimate of $0.166 by $0.064.
Is Healthstream overvalued?
According to Wall Street analysts Healthstream’s price is currently Undervalued.
Does Healthstream pay dividends?
Healthstream pays a Quarterly dividend of $0.035 which represents an annual dividend yield of 0.41%. See more information on Healthstream dividends here
What is Healthstream’s EPS estimate?
Healthstream’s EPS estimate is 0.16.
How many shares outstanding does Healthstream have?
Healthstream has 30,595,886 shares outstanding.
What happened to Healthstream’s price movement after its last earnings report?
Healthstream reported an EPS of $0.23 in its last earnings report, beating expectations of $0.166. Following the earnings report the stock price went up 5.188%.
Which hedge fund is a major shareholder of Healthstream?
Currently, no hedge funds are holding shares in HSTM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
HealthStream Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$32.50 (13.00% Upside)
$32.50 (13.00% Upside)
Hedge Fund Trend
Increased
By 191.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $4.3M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
26.30%
12-Months-Change
Fundamentals
Return on Equity
6.01%
Trailing 12-Months
Asset Growth
4.29%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Healthstream
HealthStream, Inc., established in 1990 and headquartered in Nashville, Tennessee, delivers specialized workforce and provider solutions to healthcare organizations throughout the United States. Its operations are divided into two primary segments: Workforce Solutions and Provider Solutions. The Workforce Solutions segment provides a suite of software-as-a-service (SaaS) and subscription-based tools. These comprehensive services address various aspects of healthcare staff development and management, encompassing clinical skill enhancement, talent acquisition and retention, training programs, educational resources, professional certification, scheduling logistics, competency evaluations, and performance reviews. Additionally, this segment offers support through implementation and account management. Specific applications under this umbrella cover learning platforms, performance assessment, competency tracking, disclosure management, clinical skill evaluation, simulation-based learning, quality assurance, and sector-specific training. Complementing this, the Provider Solutions segment focuses on administrative and operational needs. It includes VerityStream, an enterprise platform designed to optimize the experience for healthcare providers across diverse settings such as ambulatory surgery centers, urgent care clinics, medical groups, and other facilities. Furthermore, HealthStream offers EchoCredentialing and MSOW platforms to streamline the credentialing, enrollment, and privileging processes for medical staff in hospitals. EchoOneApp facilitates provider enrollment for medical groups. Other key offerings comprise CredentialMyDoc, a SaaS solution for credentialing and enrollment for medical groups and surgery centers; CredentialStream, another SaaS-based platform for provider credentialing, privileging, and enrollment; and NurseGrid Mobile, a dedicated application for nurse managers. These diverse solutions are marketed directly to a broad spectrum of healthcare entities, including private, non-profit, and governmental organizations, as well as pharmaceutical and medical device manufacturers.
HSTM Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a broadly positive operational and financial performance with record revenue, record adjusted EBITDA, strong product growth (notably ShiftWizard and myClinicalExchange), expanding platform capabilities (Insights/hStream) and robust cash flow and balance sheet. Management also increased guidance for revenue and adjusted EBITDA for 2026. Offsetting factors include a $2M non-recurring revenue catch-up that boosted results, rising operating expenses tied to deliberate investments (career networks, product development and sales expansion) that trimmed net income guidance, ongoing migration away from legacy products, a disclosed cybersecurity incident under investigation, and expectations for slower revenue growth in the second half. Overall, the positive items meaningfully outweigh the negatives, though investors should note the one-time revenue impact and near-term cost/investment dynamics.View all HSTM earnings summariesHSTM Stock 12 Month Forecast
Average Price Target
$32.50
▲(13.00% Upside)
Technical Analysis
Spok Holdings
―
National Research
―
Phreesia
―
Health Catalyst
―
Definitive Healthcare Corp
―
Ownership Overview
19.17% Insiders
15.40% Mutual Funds
4.10% Other Institutional Investors
39.00% Public Companies and
Individual Investors